Canopy Growth (TSX:WEED) Increases U.S. Investment: Is This Accretive to Growth?

How accretive to growth could Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) chosen U.S. strategy be?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

Canadian marijuana and hemp giant Canopy Growth Corp (TSX:WEED)(NYSE:CGC) announced a fresh hemp acquisition of a prominent United States hemp outfit on Thursday, and the company’s latest move may better position it for success in the nascent cannabis market south of the boarder.

What we know so far

The acquired company, AgriNextUSA is a hemp outfit co-founded by U.S. hemp pioneer Geoff Whaling who was a strong advocate for the newly legalized industry. The new acquisition had a strong vision to conquer the U.S. hemp market by operating at a higher level in the value chain — a view that is strongly supported by Canopy Growth.

The vision involves creating Hemp Industrial Parks “such as the one previously announced in New York State,” across America that will process the entire hemp crop “from root to tip” into “advanced materials, cosmetics, energy, fibre and textiles, food and protein production and the health and wellness” products like cannabidiol (CBD) oils while providing local farmers with regional destinations for their crop.

There seems to be a perfect strategic fit with this deal that will allow Canopy to serve several industry verticals while strongly positioning itself for a strong presence in the U.S. cannabis market in the future when it becomes federally legal to do so.

The latest acquisition’s total consideration is undisclosed, but it was on a cash basis. We’ll get more detail in the coming quarterly financial statements.

In summary, instead of buying up primary production assets like it did with cannabis in Canada, Canopy’s hemp business in the United States will be focused on manufacturing and new product development, leaving the farming of hemp to those who know it best, the American farmers.

A perfect market development strategy?

There’s cutthroat competition in the nascent U.S. hemp industry.

Unlike in Canada, where cannabis firms enjoyed some level of regulatory barriers to entry as Health Canada was a bit slow to issue new production and sales licenses to applicants, giving the early entrants some first mover advantages and wide room to knit their expansion strategies, the U.S. hemp space is a totally different playing field.

In the spirit of empowering American farmers, the new U.S. Farm Bill 2018 opened up the hemp industry to all, and there aren’t any significant barriers to market entry for those with access to the land, so a market development strategy that involves investing in primary agriculture is bound to face stiff competition from local farming communities.

Instead, investing in assets higher in the value chain is a more respectable entrepreneurial venture, and Canopy’s decision to build hemp industrial processing parks looks a better placed option in trying to conquer the new market.

How accretive?

Agriculture is a profitable business, but the value added and margins created by a company that does the processing, manufacturing and distribution may be much higher. Barley and sorghum farmers are not really as profitable as beer brewers in the alcoholic beverages market.

The new business plan allows Canopy to operate in several different industries including construction materials, synthetics and the legacy CBD cannabis oil line at a grand scale.

To think that Canopy will run multiple industrial parks in the United States stirs investor interest, especially if we deduce that the company is indeed building up some serious infrastructure that will make it a strong force to contend with in a new cannabis market when the legal framework finally allows.

Investor takeaway

Canopy Growth looks well positioned to rule the global cannabis market, and is well resourced to follow through on its expansion strategy after a $5 billion investment by Constellation Brands.

Management’s chosen strategic play in the United States looks a brilliant grant entrance by a global giant into a big, highly competitive new market and it positions the company for some significant success.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »